发明名称 Sulfonamid-metalloprotease-inhibitorer, fremgangsmåter for fremstilling og anvendelse derav, og farmasöytiske preparater sominneholder dem
摘要 <p>This invention relates to sulfamides of formula (I) wherein R<SP>10</SP> is C(O)OH or C(O)-NR<SP>11</SP>-OR<SP>12</SP> and the other R symbols may be a wide variety of substituents including where R<SP>1</SP> and R<SP>2</SP> together with the C atom to which they are attached form a carbocycle or hetrocycle, where R<SP>3</SP> and R<SP>1</SP> or R<SP>2</SP> and the atoms to which they are attached form a heterocycloamino group, where R<SP>20</SP> and R<SP>21</SP> together with the N atom to which they are attached form a heterocycloamino group and where either of R<SP>20</SP> or R<SP>21</SP> together with R<SP>3</SP> forms an alkylene group. They are inhibitors of metalloproteases, (MMP inhibitors) for use in treating disorders of connective tissue.</p>
申请公布号 NO313635(B1) 申请公布日期 2002.11.04
申请号 NO19990003587 申请日期 1999.07.22
申请人 AGOURON PHARMACEUTICALS INC 发明人 BROKA, CHRIS ALLEN;CAMPBELL, JEFFREY ALLEN;CASTELHANO, ARLINDO LUCAS;CHEN, JIAN JEFFREY;HENDRICKS, ROBERT THAN;MELNICK, MICHAEL JOSEPH;WALKER, KEITH ADRIAN MURRAY
分类号 C07D295/22;A61K31/4406;A61K31/444;A61K31/445;A61K31/4453;A61K31/4545;A61K31/495;A61K31/496;A61K31/5375;A61K31/541;A61K31/695;A61P7/00;A61P19/08;A61P29/00;A61P37/06;A61P43/00;C07C307/06;C07D211/36;C07D211/96;C07D213/74;C07D295/26;C07D309/14;C07D401/04;C07D401/12;C07F7/10;(IPC1-7):C07D295/22;C07D239/42;C07D211/46;A61K31/435 主分类号 C07D295/22
代理机构 代理人
主权项
地址